Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Patent Number 10052314

US 10052314 B2
Application Number15851444
Publication NumberUS 20180110764 A1
Pendency8 months, 3 days
Filled DateDec 21, 2017
Priority DateSep 26, 2012
Publication DateApr 26, 2018
Expiration DateSep 25, 2032
Inventor/ApplicantsIsan Chen
ExaminesHUI, SAN MING R
Art Unit1621
Technology Center1600
Assignments
Johnson & Johnson
Current
Aragon Pharmaceuticals Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.